Stock Research for SNSS

SNSS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SNSS Stock Chart & Research Data

The SNSS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SNSS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SNSS Due diligence Resources & Stock Charts

The SNSS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SNSS Detailed Price Forecast - CNN Money CNN View SNSS Detailed Summary - Google Finance
Yahoo View SNSS Detailed Summary - Yahoo! Finance Zacks View SNSS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SNSS Trends & Analysis - Trade-Ideas Barrons View SNSS Major Holders - Barrons
NASDAQ View SNSS Call Transcripts - NASDAQ Seeking View SNSS Breaking News & Analysis - Seeking Alpha
Spotlight View SNSS Annual Report - CompanySpotlight.com OTC Report View SNSS OTC Short Report - OTCShortReport.com
TradeKing View SNSS Fundamentals - TradeKing Charts View SNSS SEC Filings - Bar Chart
WSJ View Historical Prices for SNSS - The WSJ Morningstar View Performance/Total Return for SNSS - Morningstar
MarketWatch View the Analyst Estimates for SNSS - MarketWatch CNBC View the Earnings History for SNSS - CNBC
StockMarketWatch View the SNSS Earnings - StockMarketWatch MacroAxis View SNSS Buy or Sell Recommendations - MacroAxis
Bullish View the SNSS Bullish Patterns - American Bulls Short Pains View SNSS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SNSS Stock Mentions - StockTwits PennyStocks View SNSS Stock Mentions - PennyStockTweets
Twitter View SNSS Stock Mentions - Twitter Invest Hub View SNSS Investment Forum News - Investor Hub
Yahoo View SNSS Stock Mentions - Yahoo! Message Board Seeking Alpha View SNSS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SNSS - SECform4.com Insider Cow View Insider Transactions for SNSS - Insider Cow
CNBC View SNSS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SNSS - OTC Markets
Yahoo View Insider Transactions for SNSS - Yahoo! Finance NASDAQ View Institutional Holdings for SNSS - NASDAQ


Stock Charts

FinViz View SNSS Stock Insight & Charts - FinViz.com StockCharts View SNSS Investment Charts - StockCharts.com
BarChart View SNSS Stock Overview & Charts - BarChart Trading View View SNSS User Generated Charts - Trading View




Latest Financial News for SNSS


Sunesis Pharmaceuticals Strengthens Senior Management Team
Posted on Monday July 09, 2018

Sunesis Pharmaceuticals, Inc. (SNSS) today announced three key new management appointments as part of the Company’s expansion of its development team. Deepali Suri, M.Sc., a former Executive Director at Pharmacyclics (an AbbVie Company), was appointed Vice President, Clinical Operations, and Sean Gharpurey, M.S., MBA, joined as Executive Director, Project Management. Stephen Nava was promoted to Vice President, Quality Assurance, Compliance and Regulatory Affairs.


Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
Posted on Monday June 25, 2018

Sunesis Pharmaceuticals, Inc. (SNSS) today announced that it has entered into a Common Shares Purchase Agreement (the “Agreement”) of up to $15.5 million with Aspire Capital Fund, LLC (“Aspire Capital”). Under the terms of the Agreement, Aspire Capital has made an initial investment via purchase of $500,000 worth of SNSS common shares at a price of $2.19 per common share. In addition, Aspire Capital has committed to purchasing up to an additional $15 million of common shares of Sunesis, at Sunesis’ request from time to time during a 24-month period beginning on the effective date of a registration statement related to the transaction and at prices based on the market price at the time of each sale.


Sunesis Pharmaceuticals Announces Presentations at the EHA Annual Meeting
Posted on Monday June 18, 2018

Université Claude Bernard de Lyon Study Provides Preclinical Validation of Vecabrutinib Activity Against Ibrutinib-Resistant BTK C481S Mutated Lymphomas. ERIC Study Shows Half of Ibrutinib-Relapse CLL ...


5 Biotech Stocks Under $10 Worthy of Investors' Attention
Posted on Friday June 15, 2018

Small biotech stocks are good bets with lower market cap as well as share price.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.